Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP581728.RAWveq9wKIIxHw3JTqeOr1_bw44RXL4lMkxvefqTG-7as130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP581728.RAWveq9wKIIxHw3JTqeOr1_bw44RXL4lMkxvefqTG-7as130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP581728.RAWveq9wKIIxHw3JTqeOr1_bw44RXL4lMkxvefqTG-7as130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP581728.RAWveq9wKIIxHw3JTqeOr1_bw44RXL4lMkxvefqTG-7as130_provenance.
- NP581728.RAWveq9wKIIxHw3JTqeOr1_bw44RXL4lMkxvefqTG-7as130_assertion description "[We are developing MHC class II (MHC II)-matched allogeneic, cell-based uveal melanoma vaccines that activate CD4(+) T lymphocytes, which are key cells for optimizing CD8(+) T-cell immunity, facilitating immune memory, and preventing tolerance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP581728.RAWveq9wKIIxHw3JTqeOr1_bw44RXL4lMkxvefqTG-7as130_provenance.
- NP581728.RAWveq9wKIIxHw3JTqeOr1_bw44RXL4lMkxvefqTG-7as130_assertion evidence source_evidence_literature NP581728.RAWveq9wKIIxHw3JTqeOr1_bw44RXL4lMkxvefqTG-7as130_provenance.
- NP581728.RAWveq9wKIIxHw3JTqeOr1_bw44RXL4lMkxvefqTG-7as130_assertion SIO_000772 17483366 NP581728.RAWveq9wKIIxHw3JTqeOr1_bw44RXL4lMkxvefqTG-7as130_provenance.
- NP581728.RAWveq9wKIIxHw3JTqeOr1_bw44RXL4lMkxvefqTG-7as130_assertion wasDerivedFrom befree-20140225 NP581728.RAWveq9wKIIxHw3JTqeOr1_bw44RXL4lMkxvefqTG-7as130_provenance.
- NP581728.RAWveq9wKIIxHw3JTqeOr1_bw44RXL4lMkxvefqTG-7as130_assertion wasGeneratedBy ECO_0000203 NP581728.RAWveq9wKIIxHw3JTqeOr1_bw44RXL4lMkxvefqTG-7as130_provenance.
- befree-20140225 importedOn "2014-02-25" NP581728.RAWveq9wKIIxHw3JTqeOr1_bw44RXL4lMkxvefqTG-7as130_provenance.